📌 Key Takeaways
- Topic: Ultrafine Silica Powder: Particle Sizes, Specifications and Applications
- Keywords: micro silica
- Published: 2026-11-20 08:49:15
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Particle Size Guide: How D50, Mesh and Microns Affect Performance
- 600 Mesh Silica: Particle Size, Specifications and Common Applications
- Silica Free Flow Agent: Typical Dosage, Benefits and Best Grades
- High Purity Silica: Purity Levels (4N–6N), Specifications and Applications
- How Is Silica Made? Production Methods for Each Type of Silica
- Huang, J. et al. Combination wound healing utilizing polymer entangled porous nanoadhesive hybrids with robust ROS scavenging and angiogenesis properties. Acta Biomater. 152, 171-185 (2022). Article CAS PubMed Google Scholar
Tosoh Silica: Product Range, Applications and Key Grades
What is silica (SiO₂)?
colloidal silica Teng, W. et al. Toxicity evaluation of mesoporous silica particles Santa Barbara No. 15 amorphous in human umbilical vein endothelial cells: influence of particle morphology. J. Appl. Toxicol. 41, 1467-1478 (2021). Piece CAS PubMed Google Scholar
What is the difference between fumed silica and precipitated silica?
silica for optical fiber
What drives silica raw material prices?
spherical vs angular silica Targeted delivery tactics are generally divided into two categories: passive targeting and active targeting. Passive targeting relies on the pathological qualities of the disease microenvironment and the nature of the drug delivery system itself, which allows the drug to effectively accumulate at the lesion site of disease. The most well-known passive targeting is the EPR effect of tumor, which refers to the phenomenon that some particles with particular size (20-200 nm) penetrate more without difficulty into tumor tissue and remain there for a long time when compared to normal tissue. 316, 317 Therefore, controlling the size of MSNs to a fitting range will facilitate their enrichment in the tumor sites. However, it has also been highlighted that the passive targeting strategy relying on the EPR effect can attain only 0.7% of the injected NPs enrichment in solid tumors, 318 which will not be handy for the clinical translation of nanotechnology. In contrast, active targeting relies on the active recognition between the molecules on the NPs surface and the specific molecules or proteins in the illness microenvironment, which is also referred to as ligand-receptor specific binding. 319 The active targeting shows a higher drug delivery efficiency compared to passive targeting. 320 Targeted ligands, such as proteins, antibodies, peptides, nucleic acids and chemical tiny molecules, can be modified on the surface of MSNs, and the modified MSNs are capable of selectively aggregating at the lesion site based on the powerful affinity between the targeted ligands and the particular receptors overexpressed in the sickness microenvironment. 321, 322, 323, 324 For instance, compared to mature vascular endothelial cells, tumor neovascular endothelial cells are highly expressed in an array of proteins, such as integrins, transmembrane glycoproteins and aminopeptidase N. Molecules that recognize these highly expressed proteins can be used for neovascular-based targeted drug delivery. A standard example is that arginylglycylaspartic acid (RGD)-modified MSNs can selectively bind integrin α ν β 3 receptor and hence be applied to target tumor neovascularization. 325
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.